These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

328 related items for PubMed ID: 15462699

  • 1. Montelukast in asthmatic patients 6 years-14 years old with an FEV1 > 75%.
    Becker A, Swern A, Tozzi CA, Yu Q, Reiss T, Knorr B.
    Curr Med Res Opin; 2004 Oct; 20(10):1651-9. PubMed ID: 15462699
    [Abstract] [Full Text] [Related]

  • 2. Analysis of montelukast in mild persistent asthmatic patients with near-normal lung function.
    Barnes N, Wei LX, Reiss TF, Leff JA, Shingo S, Yu C, Edelman JM.
    Respir Med; 2001 May; 95(5):379-86. PubMed ID: 11392579
    [Abstract] [Full Text] [Related]

  • 3. Montelukast, a leukotriene-receptor antagonist, for the treatment of mild asthma and exercise-induced bronchoconstriction.
    Leff JA, Busse WW, Pearlman D, Bronsky EA, Kemp J, Hendeles L, Dockhorn R, Kundu S, Zhang J, Seidenberg BC, Reiss TF.
    N Engl J Med; 1998 Jul 16; 339(3):147-52. PubMed ID: 9664090
    [Abstract] [Full Text] [Related]

  • 4. Low-dose fluticasone propionate compared with montelukast for first-line treatment of persistent asthma: a randomized clinical trial.
    Busse W, Raphael GD, Galant S, Kalberg C, Goode-Sellers S, Srebro S, Edwards L, Rickard K, Fluticasone Proprionate Clinical Research Study Group.
    J Allergy Clin Immunol; 2001 Mar 16; 107(3):461-8. PubMed ID: 11240946
    [Abstract] [Full Text] [Related]

  • 5. The efficacy of montelukast during the allergy season in pediatric patients with persistent asthma and seasonal aeroallergen sensitivity.
    Papadopoulos NG, Philip G, Giezek H, Watkins M, Smugar SS, Polos PG.
    J Asthma; 2009 May 16; 46(4):413-20. PubMed ID: 19484680
    [Abstract] [Full Text] [Related]

  • 6. Efficacy and tolerability of salmeterol/fluticasone propionate versus montelukast in childhood asthma: A prospective, randomized, double-blind, double-dummy, parallel-group study.
    Maspero J, Guerra F, Cuevas F, Gutierrez JP, Soto-Ramos M, Anderton S, Mechali D, Chan R, Pedersen S.
    Clin Ther; 2008 Aug 16; 30(8):1492-504. PubMed ID: 18803991
    [Abstract] [Full Text] [Related]

  • 7. Effectiveness of montelukast in the treatment of cough variant asthma.
    Spector SL, Tan RA.
    Ann Allergy Asthma Immunol; 2004 Sep 16; 93(3):232-6. PubMed ID: 15478381
    [Abstract] [Full Text] [Related]

  • 8. Pilot study of oral montelukast added to standard therapy for acute asthma exacerbations in children aged 6 to 14 years.
    Nelson KA, Smith SR, Trinkaus K, Jaffe DM.
    Pediatr Emerg Care; 2008 Jan 16; 24(1):21-7. PubMed ID: 18165796
    [Abstract] [Full Text] [Related]

  • 9. A randomized study comparing the effect of loratadine added to montelukast with montelukast, loratadine, and beclomethasone monotherapies in patients with chronic asthma.
    Lu S, Liu N, Dass SB, Reiss TF.
    J Asthma; 2009 Jun 16; 46(5):465-9. PubMed ID: 19544166
    [Abstract] [Full Text] [Related]

  • 10. Efficacy of montelukast during the allergy season in patients with chronic asthma and seasonal aeroallergen sensitivity.
    Busse WW, Casale TB, Dykewicz MS, Meltzer EO, Bird SR, Hustad CM, Grant E, Zeldin RK, Edelman JM.
    Ann Allergy Asthma Immunol; 2006 Jan 16; 96(1):60-8. PubMed ID: 16440534
    [Abstract] [Full Text] [Related]

  • 11. The effect of treatment with montelukast on levels of serum interleukin-10, eosinophil cationic protein, blood eosinophil counts, and clinical parameters in children with asthma.
    Yüksel B, Aydemir C, Ustündag G, Eldeş N, Kutsal E, Can M, Demirtaş S, Tomaç N.
    Turk J Pediatr; 2009 Jan 16; 51(5):460-5. PubMed ID: 20112601
    [Abstract] [Full Text] [Related]

  • 12. Improvement of aspirin-intolerant asthma by montelukast, a leukotriene antagonist: a randomized, double-blind, placebo-controlled trial.
    Dahlén SE, Malmström K, Nizankowska E, Dahlén B, Kuna P, Kowalski M, Lumry WR, Picado C, Stevenson DD, Bousquet J, Pauwels R, Holgate ST, Shahane A, Zhang J, Reiss TF, Szczeklik A.
    Am J Respir Crit Care Med; 2002 Jan 01; 165(1):9-14. PubMed ID: 11779723
    [Abstract] [Full Text] [Related]

  • 13. Comparative efficacy and safety of low-dose fluticasone propionate and montelukast in children with persistent asthma.
    Ostrom NK, Decotiis BA, Lincourt WR, Edwards LD, Hanson KM, Carranza Rosenzweig JR, Crim C.
    J Pediatr; 2005 Aug 01; 147(2):213-20. PubMed ID: 16126052
    [Abstract] [Full Text] [Related]

  • 14. Oral montelukast versus inhaled beclomethasone in 6- to 11-year-old children with asthma: results of an open-label extension study evaluating long-term safety, satisfaction, and adherence with therapy.
    Maspero JF, Dueñas-Meza E, Volovitz B, Pinacho Daza C, Kosa L, Vrijens F, Leff JA.
    Curr Med Res Opin; 2001 Aug 01; 17(2):96-104. PubMed ID: 11759189
    [Abstract] [Full Text] [Related]

  • 15. Montelukast, compared with fluticasone, for control of asthma among 6- to 14-year-old patients with mild asthma: the MOSAIC study.
    Garcia Garcia ML, Wahn U, Gilles L, Swern A, Tozzi CA, Polos P.
    Pediatrics; 2005 Aug 01; 116(2):360-9. PubMed ID: 16061590
    [Abstract] [Full Text] [Related]

  • 16. Montelukast and bronchial inflammation in asthma: a randomised, double-blind placebo-controlled trial.
    Ramsay CF, Sullivan P, Gizycki M, Wang D, Swern AS, Barnes NC, Reiss TF, Jeffery PK.
    Respir Med; 2009 Jul 01; 103(7):995-1003. PubMed ID: 19249198
    [Abstract] [Full Text] [Related]

  • 17. Effect of addition of single dose of oral montelukast to standard treatment in acute moderate to severe asthma in children between 5 and 15 years of age: a randomised, double-blind, placebo controlled trial.
    Todi VK, Lodha R, Kabra SK.
    Arch Dis Child; 2010 Jul 01; 95(7):540-3. PubMed ID: 20522464
    [Abstract] [Full Text] [Related]

  • 18. Effect of montelukast on peripheral airflow obstruction in children with asthma.
    Spahn JD, Covar RA, Jain N, Gleason M, Shimamoto R, Szefler SJ, Gelfand EW.
    Ann Allergy Asthma Immunol; 2006 Apr 01; 96(4):541-9. PubMed ID: 16680924
    [Abstract] [Full Text] [Related]

  • 19. [Single dose of montelukast as an effective prevention of post exercise bronchospasm in children with bronchial asthma].
    Gaszczyk G, Latoś T, Słowikowski A, Janiak B.
    Med Wieku Rozwoj; 2004 Apr 01; 8(3 Pt 2):847-56. PubMed ID: 15858257
    [Abstract] [Full Text] [Related]

  • 20. Pretreatment with albuterol versus montelukast for exercise-induced bronchospasm in children.
    Raissy HH, Harkins M, Kelly F, Kelly HW.
    Pharmacotherapy; 2008 Mar 01; 28(3):287-94. PubMed ID: 18294107
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.